Skip to content
PulseMS
Log inJoin
Research & community

MS research, together.

MS research in plain English. Perspectives from people who understand.

Research evidence filters

Filters apply to reviewed research. Unknown dates and unassessed posts are excluded when a corresponding filter is active.

Reset filters
Topics & sourcesFiltered
Popular posts, ranked by community votes and recency.AI researchClear filters
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedHuman studyObservationalPeer review unconfirmed

Effects of Fingolimod on Lymphocyte Levels in Human MS Patients

In a study of 143 adults with MS on fingolimod, 86.7% experienced lymphopenia at 6 months, including 10.5% with severe Grade 4 lymphopenia. Significant decreases in leukocyte, neutrophil, and lymphocyte counts were observed, along with increases in liver enzyme levels. Notably, no significant infection risk was linked to Grade 3-4 lymphopenia, and lower baseline lymphocyte counts correlated with severe lymphopenia.

What this does not proveThe lack of a significant correlation between lymphopenia severity and infection risk limits the reliability of these findings. Additionally, the small number of Grade 4 cases restricts the ability to draw broad conclusions.
#Fingolimod#Lymphopenia#InfectionRisk#HematologicalMonitoringRelevant to Neurologist, Immunologist
View abstract on PubMedPMID 42796323AI summary of a published abstract. Not medical advice.
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedHuman studyObservationalPeer review unconfirmed

Human Study on Cervical Cord Atrophy in MS Patients

In a study with 1,295 patients with MS, researchers found that cervical cord area (mean upper cervical cord area) was reduced starting at age 30 compared to healthy controls. Additionally, greater cervical cord atrophy was linked to higher disability and worse MRI measures.

What this does not proveThe study cannot establish causality due to its cross-sectional design and lacks longitudinal data. The observed differences related to disease duration may not directly reflect age at onset's influence on atrophy.
#MSResearch
View abstract on PubMedPMID 42814910AI summary of a published abstract. Not medical advice.
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedHuman studyNot reportedTrial registry

Patient Satisfaction with Subcutaneous Ocrelizumab in RRMS Patients

The study aims to assess patient satisfaction with subcutaneous ocrelizumab administration in patients with relapsing-remitting multiple sclerosis (RRMS) over a 12-month follow-up period.

What this does not proveNo results are posted, and planned enrolment and endpoints do not constitute findings.
#MSResearch
View abstract on PubMedAI summary of a published abstract. Not medical advice.
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedHuman studyNot reportedTrial registry

Study Invoking Human Subjects with MS Diagnosis

The study aims to confirm the diagnosis and subtype of multiple sclerosis (MS) by comparing tests on healthy individuals with those on patients who have immune-related CNS damage.

What this does not proveNo results have been reported yet, and specific endpoints or planned enrollment details are not established, preventing conclusions from being drawn about the study's efficacy or outcomes.
#MSResearch
View abstract on PubMedAI summary of a published abstract. Not medical advice.
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedHuman studyInterventionalTrial registry

Eccentric Cycling Training in People with Multiple Sclerosis

This ongoing interventional study aims to determine the best parameters for eccentric cycling training in individuals with multiple sclerosis, comparing its effectiveness to traditional rehabilitation methods. Approximately 60 to 80 participants with neurological disorders will be included to assess maximal force during cycling exercises.

What this does not proveNo results have been published, and thus, there are no conclusions drawn about efficacy or safety at this stage. The study is still in the process of enrolling participants.
#Rehabilitation
View abstract on PubMedAI summary of a published abstract. Not medical advice.
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedHuman studyObservationalTrial registry

Immune Biomarkers and Functional Performance in Multiple Sclerosis Patients

This observational study with 20 MS patients evaluated the relationship between peripheral immune biomarkers and their functional performance, specifically using the Multiple Sclerosis Functional Composite (MSFC) measurements. The biomarkers measured included tumor necrosis factor-alpha, interleukin-8, and adiponectin, without any therapeutic interventions introduced.

What this does not proveThe study is purely observational, relying on correlational data without therapeutic interventions or controls; results are pending due to an unknown publication date.
#MSResearch
View abstract on PubMedAI summary of a published abstract. Not medical advice.
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedSubjects not reportedNot reportedPeer review unconfirmed

Animal Study with EBV Peptide Microarray

In a study involving 329 specimens, researchers validated a peptide microarray targeting nine EBV proteins. They found broad EBV humoral reactivity in individuals with infectious mononucleosis (IM), multiple sclerosis (MS), and non-MS donors. Notably, they replicated patterns of EBNA-1 C-terminal reactivity associated with MS but determined that overall EBV reactivity does not provide a clear signal to distinguish MS from non-MS samples.

What this does not proveThe study did not provide a straightforward MS-discriminating profile. Furthermore, only a limited number of EBV epitopes were relevant to distinguishing MS from other cohorts, indicating that broad EBV exposure is not unique to MS.
#EBV
View abstract on PubMedPMID 42756034AI summary of a published abstract. Not medical advice.
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedHuman studySystematic reviewPeer review unconfirmed

Sleep Issues in Caregivers of People with MS

A scoping review found that 38.6% to 72.1% of caregivers for people with multiple sclerosis (MS) reported poor sleep. Comparatively, these caregivers faced more sleep difficulties than non-caregiver controls. Moreover, poor sleep quality was linked to higher levels of anxiety and depression.

What this does not proveThe review primarily relied on subjective measures of sleep, with no studies using objective measures, and varied assessment methods limited the ability to compare results directly.
#MSResearch
View abstract on PubMedPMID 42815169AI summary of a published abstract. Not medical advice.
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedHuman studyObservationalPeer review unconfirmed

Longitudinal Gut Microbiome Study in Relapsing-Remitting MS Patients

In a study of 29 treatment-naïve patients with relapsing-remitting multiple sclerosis (RRMS), gut microbiota composition and diversity remained stable over one year. While there was a trend indicating that worsening disability (measured by EDSS) correlated with increased microbiome instability, this did not reach statistical significance. Additionally, GFAP levels increased significantly, while NfL levels decreased and S100B levels remained unchanged.

What this does not proveThe study's exploratory analyses noted that significant associations found did not hold after adjustments for multiple testing. Moreover, the small sample size necessitates larger longitudinal studies to better understand these relationships.
#GutHealth#Disability#Biomarkers#SymptomMgmtRelevant to Neurologist, Immunologist
View abstract on PubMedPMID 42795661AI summary of a published abstract. Not medical advice.
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedHuman studyObservationalPeer review unconfirmed

Place and Cause of Death in Chronic Neurological Diseases (Including MS)

A study reviewing death certificates in Munich found that 43.8% of deaths occurred in hospitals, 25.9% in nursing homes, and 25.0% at home. Neurological diseases were listed as the immediate or underlying cause of death in 57.3% of cases.

What this does not proveThis study does not establish causal relationships for mortality or specifically for MS, as it is based solely on death certificates.
#MSResearch
View abstract on PubMedPMID 42839248AI summary of a published abstract. Not medical advice.